Molecular imaging is redefining in vivo characterization of multiple sclerosis, a demyelinating disease with complex and heterogeneous clinical profiles. Recent advances in PET tracers enable more ...

AI has fundamentally altered the feasibility of natural product discovery from fungal endophytes. Advances in genome ...

Investing.com -- Omeros Corporation (NASDAQ:OMER) stock rose 3.1% on Tuesday after the company announced it has completed its ...

Omeros Corporation (NASDAQ: OMER) today announced that the first commercial shipments of YARTEMLEA® (narsoplimab-wuug) to its ...

Hydrogels are among the most widely studied biomaterials in modern drug delivery research. Their high hydrophilicity, ...

Performances in N.Y.C. Advertisement Supported by Listen to recordings by Maria Dueñas and Daniil Trifonov, works by Thomas Adès and Tania León, and more. London Philharmonic Orchestra; Thomas Adès, ...

Performances in N.Y.C. Advertisement Supported by A holiday album that cuts through seasonal glut, a late collaboration by Jim McNeely and Helmut Lachenmann’s string quartets are among the highlights.

The classical pathway for complement activation is initiated by the formation of a complex between C1q and an antigen-antibody complex, setting off a cascade of proteolytic events that culminate in ...

Light and heavy chain deposition disease (LHCDD) is a clonal plasma cell or monoclonal B-cell dyscrasia characterized by deposition of monoclonal immunoglobulin light and heavy chains. LHCDD mainly ...

The triple therapy showed a 50% overall response rate and 22-month median overall survival in MSS BRAF V600E-mutant mCRC patients. Targeting MAPK signaling with encorafenib and cetuximab may prime ...